Guardant Health Inc (NASDAQ:GH)’s traded shares stood at 1.82 million during the latest session, with the company’s beta value hitting 0.85. At the last check today, the stock’s price was $19.88, to imply an increase of 10.69% or $1.92 in intraday trading. The GH share’s 52-week high remains $41.06, putting it -106.54% down since that peak but still an impressive 14.89% since price per share fell to its 52-week low of $16.92. The company has a valuation of $2.42B, with an average of 1.87 million shares in intraday trading volume over the past 10 days and average of 1.68 million shares over the past 3 months.
Guardant Health Inc (NASDAQ:GH) trade information
After registering a 10.69% upside in the latest session, Guardant Health Inc (GH) has traded red over the past five days. The stock hit a weekly high of 19.47, jumping 10.69% in its intraday price action. The 5-day price performance for the stock is 13.21%, and 6.14% over 30 days. With these gigs, the year-to-date price performance is -26.51%. Short interest in Guardant Health Inc (NASDAQ:GH) saw shorts transact 7.76 million shares and set a 3.91 days time to cover.
Guardant Health Inc (GH) estimates and forecasts
Looking at statistics comparing Guardant Health Inc share performance against respective industry, we note that the company has outperformed competitors. Guardant Health Inc (GH) shares are -28.02% down over the last 6 months, with its year-to-date growth rate higher than industry average at 18.22% against 12.70%. Revenue is forecast to grow 35.40% this quarter before falling -19.40% for the next one. The rating firms project that company’s revenue will grow 17.70% compared to the previous financial year.
Revenue forecast for the current quarter as set by 18 analysts is $150.42 million. Meanwhile, for the quarter ending Jun 2024, a total of 18 analyst(s) estimate revenue growth to $160.99 million.Earnings reports from the last fiscal year show that sales brought in $128.71 million and $137.15 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 16.90% before jumping 17.40% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -8.88% for the past 5-year period. While 2024 is set for a 23.38% return in earnings, projections for the next 5 years are at 27.80% annually.
GH Dividends
Guardant Health Inc has its next earnings report out between May 07 and May 13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Guardant Health Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Guardant Health Inc (NASDAQ:GH)’s Major holders
Guardant Health Inc insiders hold 4.15% of total outstanding shares, with institutional holders owning 92.19% of the shares at 96.18% float percentage. In total, 92.19% institutions holds shares in the company, led by Vanguard Group Inc. As of Dec 30, 2023, the company held over 11.13 million shares (or 9.15% of shares), all amounting to roughly $220.44 million.
The next major institution holding the largest number of shares is Blackrock Inc. with 10.83 million shares, or about 8.90% of shares outstanding. As of the market price on Dec 30, 2023, these shares were worth $214.52 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund as the top two Mutual Funds with the largest holdings of the Guardant Health Inc (GH) shares. Going by data provided on Dec 30, 2023, Vanguard Total Stock Market Index Fund holds roughly 3.52 million shares. This is just over 2.89% of the total shares, with a market valuation of $69.66 million. Data from the same date shows that the other fund manager holds a little less at 2.85 million, or 2.34% of the shares, all valued at about 56.52 million.
